+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030- Product Image
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030- Product Image
New

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5853876
Description Jump to:
The Respiratory Disease Vaccine Market was valued at USD 62.76 billion in 2024, and is projected to reach USD 70.30 billion by 2030, rising at a CAGR of 2.90%. The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology. Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.

Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19. In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2. The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.

Moreover, government backing and surveillance at both national and global levels to monitor the availability, dissemination, and implementation of influenza vaccines is a crucial factor driving the growth of the market. Additionally, increased investments by prominent key players with a major focus on the introduction of novel vaccines into the market have contributed to the growth of the market. For instance, Pfizer recently disclosed their plans to commence Phase 3 clinical trials for their mRNA-based influenza vaccine in September 2022. This trial will involve a cohort of 25,000 individuals aged 18 and above from the U.S.

Furthermore, key players involved in developing and formulating various respiratory disease vaccines are focusing on collaborations and partnerships to develop novel vaccines and to maintain their competitive position in the market. In addition, increasing interest in plant-based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in the elderly population above the age of 60 years.

Respiratory Disease Vaccine Market Report Highlights

  • Based on type, the viral vaccine segment held the largest market share of 54.84% in 2024 owing to the increasing prevalence of viral respiratory conditions
  • Based on age group, the pediatric segment is expected to show the fastest growth rate over the forecast period owing to the rising formulation of vaccines for the pediatric population
  • On the basis of infection, The COVID-19 segment held the largest market share of 40.03% in 2024 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence
  • North America's respiratory disease vaccine market is expected to grow strongly over the forecast period which can be attributed to the presence of key players, rising healthcare infrastructure, growing cases of chronic disorders, and availability of proper vaccination service

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Respiratory Disease Vaccine Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Respiratory Disease Vaccine Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Respiratory Disease Vaccine Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Respiratory Disease Vaccine Market: Type Movement Analysis, 2024 & 2030 (USD Million)
4.3. Viral Vaccine
4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Bacterial Vaccine
4.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Combination Vaccine
4.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Respiratory Disease Vaccine Market: Age Group Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Respiratory Disease Vaccine Market: Age Group Movement Analysis, 2024 & 2030 (USD Million)
5.3. Pediatric
5.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Adult
5.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Respiratory Disease Vaccine Market: Infection Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Respiratory Disease Vaccine Market: Infection Movement Analysis, 2024 & 2030 (USD Million)
6.3. COVID-19
6.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Influenza
6.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Respiratory Syncytial Virus (RSV)
6.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Pneumonia
6.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Others
6.7.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Respiratory Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
7.3. Hospital & Retail Pharmacies
7.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Government Suppliers
7.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Others
7.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Respiratory Disease Vaccine Market: Regional Estimates & Trend Analysis
8.1. Respiratory Disease Vaccine Market Share, By Region, 2024 & 2030, USD Million
8.2. North America
8.2.1. North America Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. France Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. China Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. India Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Respiratory Disease Vaccine Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. GSK plc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Johnson & Johnson Services, Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Pfizer Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Sanofi
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Serum Institute of India Pvt. Ltd.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. SINOVAC
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Bavarian Nordic
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Merck & Co., Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. AstraZeneca
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. EMERGENT
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Novavax
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. INOVIO Pharmaceuticals
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
9.4.13. Moderna, Inc.
9.4.13.1. Participant’s Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Respiratory Disease Vaccine Market, By Region, 2018-2030 (USD Million)
Table 4 Global Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 5 Global Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 6 Global Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 7 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 8 North America Respiratory Disease Vaccine Market, By Country, 2018-2030 (USD Million)
Table 9 North America Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 10 North America Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 11 North America Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 12 North America Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 13 U.S. Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 14 U.S. Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 15 U.S. Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 16 U.S. Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 17 Canada Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 18 Canada Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 19 Canada Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 20 Canada Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 21 Mexico Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 22 Mexico Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 23 Mexico Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 24 Mexico Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 25 Europe Respiratory Disease Vaccine Market, By Country, 2018-2030 (USD Million)
Table 26 Europe Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 27 Europe Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 28 Europe Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 29 Europe Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 30 Germany Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 31 Germany Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 32 Germany Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 33 Germany Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 34 UK Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 35 UK Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 36 UK Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 37 UK Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 38 France Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 39 France Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 40 France Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 41 France Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 42 Italy Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 43 Italy Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 44 Italy Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 45 Italy Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 46 Spain Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 47 Spain Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 48 Spain Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 49 Spain Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 50 Denmark Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 51 Denmark Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 52 Denmark Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 53 Denmark Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 54 Sweden Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 55 Sweden Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 56 Sweden Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 57 Sweden Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 58 Norway Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 59 Norway Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 60 Norway Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 61 Norway Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 62 Asia Pacific Respiratory Disease Vaccine Market, By Country, 2018-2030 (USD Million)
Table 63 Asia Pacific Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 64 Asia Pacific Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 65 Asia Pacific Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 66 Asia Pacific Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 67 Japan Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 68 Japan Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 69 Japan Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 70 Japan Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 71 China Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 72 China Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 73 China Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 74 China Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 75 India Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 76 India Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 77 India Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 78 India Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 79 South Korea Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 80 South Korea Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 81 South Korea Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 82 South Korea Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 83 Australia Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 84 Australia Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 85 Australia Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 86 Australia Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 87 Thailand Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 88 Thailand Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 89 Thailand Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 90 Thailand Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 91 Latin America Respiratory Disease Vaccine Market, By Country, 2018-2030 (USD Million)
Table 92 Latin America Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 93 Latin America Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 94 Latin America Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 95 Latin America Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 96 Brazil Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 97 Brazil Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 98 Brazil Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 99 Brazil Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 100 Argentina Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 101 Argentina Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 102 Argentina Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 103 Argentina Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 104 Middle East & Africa Respiratory Disease Vaccine Market, By Country, 2018-2030 (USD Million)
Table 105 Middle East & Africa Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 106 Middle East & Africa Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 107 Middle East & Africa Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 108 Middle East & Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 109 Saudi Arabia Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 110 Saudi Arabia Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 111 Saudi Arabia Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 112 Saudi Arabia Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 113 South Africa Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 114 South Africa Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 115 South Africa Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 116 South Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 117 UAE Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 118 UAE Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 119 UAE Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 120 UAE Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
Table 121 Kuwait Respiratory Disease Vaccine Market, By Type, 2018-2030 (USD Million)
Table 122 Kuwait Respiratory Disease Vaccine Market, By Age Group, 2018-2030 (USD Million)
Table 123 Kuwait Respiratory Disease Vaccine Market, By Infection, 2018-2030 (USD Million)
Table 124 Kuwait Respiratory Disease Vaccine Market, By Distribution Channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Respiratory disease vaccine market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Respiratory disease vaccine market: Type outlook key takeaways
Figure 20 Respiratory disease vaccine market: Type movement analysis
Figure 21 Viral vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Bacterial vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Combination vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Respiratory disease vaccine market: Age Group outlook key takeaways
Figure 25 Respiratory disease vaccine market: Age Group movement analysis
Figure 26 Pediatric market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Adult market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Respiratory disease vaccine market: Infection outlook key takeaways
Figure 29 Respiratory disease vaccine market: Infection movement analysis
Figure 30 COVID-19 market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Influenza market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Respiratory Syncytial Virus (RSV) market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Pneumonia market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Respiratory disease vaccine market: Distribution Channel outlook key takeaways
Figure 36 Respiratory disease vaccine market: Distribution Channel movement analysis
Figure 37 Hospital & Retail Pharmacies market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Government Suppliers market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Regional marketplace outlook, 2024 & 2030 (USD million)
Figure 41 Regional marketplace: Key takeaways
Figure 42 North America Respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Key country dynamics
Figure 44 U.S. Respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Key country dynamics
Figure 46 Canada respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Key country dynamics
Figure 48 Mexico respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Europe respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 UK respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Key country dynamics
Figure 53 Germany respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key country dynamics
Figure 55 France respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Key country dynamics
Figure 57 Spain respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Key country dynamics
Figure 59 Italy respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Key country dynamics
Figure 61 Denmark respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 Sweden respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Norway respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Asia Pacific respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 Japan respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 China respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 India respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Key country dynamics
Figure 74 Australia respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 76 South Korea respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 Thailand respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Latin America respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 81 Brazil respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Argentina respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 83 Middle East & Africa respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 South Africa respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Saudi Arabia respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 UAE respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Kuwait respiratory disease vaccine market estimates and forecasts, 2018-2030 (USD Million)
Figure 88 Market participant categorization
Figure 89 respiratory disease vaccine market position analysis, 2024
Figure 90 Strategic framework

Companies Mentioned

The major companies featured in this Respiratory Disease Vaccine market report include:
  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • SINOVAC
  • Bavarian Nordic
  • Merck & Co., Inc.
  • AstraZeneca
  • EMERGENT
  • Novavax
  • INOVIO Pharmaceuticals
  • Moderna, Inc.

Related Topics

Related Reports

Respiratory Disease Vaccine Market by Vaccine Type, Age Group, Distribution Channel, End User, Route Of Administration - Global Forecast to 2030 - Product Image

Respiratory Disease Vaccine Market by Vaccine Type, Age Group, Distribution Channel, End User, Route Of Administration - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Respiratory Disease Vaccines - Global Strategic Business Report - Product Image

Respiratory Disease Vaccines - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Respiratory Disease Vaccine Market Report 2025 - Product Image

Respiratory Disease Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
COVID-19 Vaccines Market by Vaccine Technology, Distribution Channel, Dosage Regimen, End User, Application Route, Packaging Type, Procurement Model - Global Forecast to 2030 - Product Image

COVID-19 Vaccines Market by Vaccine Technology, Distribution Channel, Dosage Regimen, End User, Application Route, Packaging Type, Procurement Model - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.